Literature DB >> 8741038

Three missense mutations in the galactose-1-phosphate uridyltransferase gene of three families with mild galactosaemia.

Y S Shin1, B S Gathof, T Podskarbi, M Sommer, R Giugliani, U Gresser.   

Abstract

UNLABELLED: Classical galactosaemia caused by deficiency of galactose-1-phosphate uridyltransferase (GALT) is characterized by acute symptoms of hepatocellular dysfunction, sepsis, cataracts and failure to thrive. Galactose limitation reverses these complications immediately, however, most of these children have a long-term complication of verbal dyspraxia mental retardation and ovarian failure. The GALT gene was cloned and several mutations including the common Q188R have been reported. In this study the coding region of GALT was amplified by polymerase chain reaction from genomic DNA of classical galactosaemic individuals and characterized by direct sequencing of the products. Three missense mutations were identified in three patients with a mild galactosaemic variant: (1) replacement of threonine-138 by methionine (T138M); (2) replacement of arginine by tryptophan (R259W); and (3) replacement of threonine by alanine (T350A). All three galactosaemic individuals, one girl and two boys, have varying degrees of residual GALT activity in RBC and their galactose-1-phosphate levels decreased much faster than in other galactosaemic patients. These missense mutations occur in regions that are not highly conserved domains.
CONCLUSION: The study of the molecular basis related to the phenotype variation may indeed help to prognosticate the outcome of patients with classical galactosaemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741038     DOI: 10.1007/bf01955270

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Characterization of two missense mutations in human galactose-1-phosphate uridyltransferase: different molecular mechanisms for galactosemia.

Authors:  J K Reichardt; J W Belmont; H L Levy; S L Woo
Journal:  Genomics       Date:  1992-03       Impact factor: 5.736

2.  Studies of DNA in galactose-1-phosphate uridyltransferase deficiency and the Duarte variant in Germany.

Authors:  T Podskarbi; J Reichardt; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  A common mutation associated with the Duarte galactosemia allele.

Authors:  L J Elsas; P P Dembure; S Langley; E M Paulk; L N Hjelm; J Fridovich-Keil
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

4.  Characterization of two stop codon mutations in the galactose-1-phosphate uridyltransferase gene of three male galactosemic patients with severe clinical manifestation.

Authors:  B S Gathof; M Sommer; T Podskarbi; J Reichardt; A Braun; U Gresser; Y S Shin
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

5.  Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene.

Authors:  F R Kaufman; J K Reichardt; W G Ng; Y K Xu; F R Manis; C McBride-Chang; J A Wolff
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

6.  Biochemical and molecular studies of 132 patients with galactosemia.

Authors:  W G Ng; Y K Xu; F R Kaufman; G N Donnell; J Wolff; R J Allen; S Koritala; J K Reichardt
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

7.  The human galactose-1-phosphate uridyltransferase gene.

Authors:  N D Leslie; E B Immerman; J E Flach; M Florez; J L Fridovich-Keil; L J Elsas
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

Review 8.  Genetic basis of galactosemia.

Authors:  J K Reichardt
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes.

Authors:  L J Elsas; S Langley; E Steele; J Evinger; J L Fridovich-Keil; A Brown; R Singh; P Fernhoff; L N Hjelm; P P Dembure
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

View more
  5 in total

1.  Molecular and biochemical basis for variants and deficiency forms of galactose-1-phosphate uridyltransferase.

Authors:  Y S Shin; J Zschocke; A M Das; T Podskarbi
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia.

Authors:  L Wells; J L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-1-phosphate uridyltransferase.

Authors:  T Podskarbi; T Kohlmetz; B S Gathof; B Kleinlein; W P Bieger; U Gresser; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Simultaneous amplification, detection, and analysis of common mutations in the galactose-1-phosphate uridyl transferase gene.

Authors:  Mohamed Jama; Lesa Nelson; Genevieve Pont-Kingdon; Rong Mao; Elaine Lyon
Journal:  J Mol Diagn       Date:  2007-09-20       Impact factor: 5.568

5.  Mutations in the galactose-1-phosphate uridyltransferase gene of two families with mild galactosaemia variants.

Authors:  M Sommer; B S Gathof; T Podskarbi; R Giugliani; B Kleinlein; Y S Shin
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.